Incyte

United Therapeutics

Gilead Sciences

Vertex Pharmaceuticals

AbbVie

Viking Therapeutics

Natera

Alnylam Pharmaceuticals

Neurocrine Biosciences

Amgen

Direxion Daily S&P Biotech Bull 3X Shares

LABU provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.

Direxion Daily Semiconductor Bull 3x Shares

Direxion's Dave Mazza is seeing many traders using inverse and leveraged ETFs in the recent market movement.

Taking On Volatility With Geared ETFs

LABU, a triple ETF (3x) from Direxion Funds, tracks the S&P Biotechnology Select Industry Index.

LABU - A Compelling Biotech Trade

Biogen

SPDR S&P Biotech ETF

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

3 Biotech Stocks to Buy That Are Under Severe Pressure

MMs “fill” Institutional huge Block-Trades by borrowing otherwise unavailable shares, sell short, hedge the short risk, ultimately cover shorts in accommodative market periods. Short-risk hedge-sellers engineer their profitable postures using high-leverage derivative securities and arbitrage skills not typically available to the investing public.

LABU: Now Best Near-Term Cap Gain Among Leveraged-Long ETFs Say Market-Maker Hedging Deals

Direxion Daily S&P Biotech Bear 3X Shares

A bearish sentiment in biotechnology took over in the second half of 2021, providing gains for the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed almost 21% in the second half of 2021, giving bearish biotech traders something to cheer about.

Biotech Belonged to the Bears in Second Half of 2021

Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares

BMO REX MicroSectors FANG+ Index -3X Inverse Leveraged ETN

ProShares UltraShort FTSE China 50

Direxion Daily S&P 500 High Beta Bear 3X Shares

ProShares UltraShort Bloomberg Natural Gas

MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETNs

MicroSectors Oil & Gas Exploration & Production -3X Inverse Leveraged ETN

Direxion Daily Technology Bear 3X Shares

Direxion Daily FTSE China Bear 3X Shares

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 12/19/2021

The Omicron variant re-asserted the strength of biotech equities, making the Direxion Daily S&P Biotech Bull 3x Shares (LABU) an option for traders. As investors turned up the risk dial, COVID-19 cases ticked up towards the end of the year, and now with the new variant, they can provide an attractive option for a short-term [.

Omicron Variant Is Boosting This Leveraged Biotech ETF

Direxion Daily S&P Biotech Bull 3X Shares ETF is a biotechnology focused passive fund. The fund is aimed at providing three times the daily performance of its benchmark index.

LABU Provides Leveraged Access For Risk-Taking Investors

Apple

Direxion Daily Energy Bear 2X Shares

BMO REX MicroSectors FANG+ Index 3X Leveraged ETN

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

iShares Russell 2000 ETF

Bank of Montreal - MicroSectors U.S. Big Oil Index 3X Leveraged ETNs

Invesco QQQ

SPDR S&P 500 ETF Trust

Direxion Daily 20+ Year Treasury Bear 3X Shares

Direxion Daily Utilities Bull 3X Shares

Invesco DB US Dollar Index Bullish Fund

This is the first public release of the weekly ETF/ETN forecast article, highlighting some strong sectors, index funds and commodities for your consideration. This report goes out weekly with live daily updates for members and may continue monthly for other readers of my articles.

ETF/ETN Breakouts Week 39 - September 2021: Short-Term Funds To Give You An Edge

Direxion Daily MSCI India Bull 2X Shares

Direxion Daily Technology Bull 3x Shares

ProShares UltraPro QQQ

The MSCI's broadest index of world stocks on its best run of monthly gains since 2017-2018.

5 Best-Performing Leveraged ETFs of August

Direxion Daily CSI China Internet Index Bull 2X Shares

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily S&P 500 High Beta Bull 3X Shares

ETFMG Prime 2x Daily Junior Silver Miners ETF

Wall Street was upbeat last week. News of zero new cases in China, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine and no new flare-up in taper talks led to the gains.

7 Best Leveraged ETF Areas of Last Week

ProShares Ultra Nasdaq Biotechnology

Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.

Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs

ARK Genomic Revolution Multi-Sector ETF

ARK Innovation ETF

ARK Industrial Innovation ETF

ARK Web x.0 ETF

ARK Active ETFs are worth the management fee. Structured Lookback is introduced.

ARK: Cathie Wood And The Exquisite Art Of Tail Gunning

Annovis Bio

Arvinas Inc

Anavex Life Sciences

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Biohaven Pharmaceutical Hld

Loncar Cancer Immunotherapy ETF

Denali Therapeutics

First Trust NYSE Arca Biotechnology Index Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

abrdn Life Sciences Investors 

iShares Nasdaq Biotechnology ETF

Defiance Nasdaq Junior Biotechnology ETF

INmune Bio Inc

Intra-Cellular Therapies

Karuna Therapeutics Inc

Eli Lilly

Invesco Dynamic Biotechnology & Genome ETF

Prothena

Cassava Sciences Inc

Supernus Pharmaceuticals

Health Care Select Sector SPDR Fund

Biotechs are ready to march forcefully higher after a lengthy consolidation. Approval of Biogen's Alzheimer's treatment creates a bonanza for neurodegenerative-focused companies and the overall biotech sector.

Biotechs Ready To Roar

The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQ: BIIB). The FDA approved its controverisal drug that can treat Alzheimer's Disease.

A Biotech ETF For Aggressive, Risk-Tolerant Investors

Principal Healthcare Innovators Index ETF

Direxion Daily Healthcare Bull 3x Shares

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

abrdn Healthcare Investors 

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

John Hancock Multifactor Healthcare ETF

Global X Longevity Thematic ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

ProShares UltraShort Health Care

ProShares Ultra Health Care

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

Pacer BioThreat ETF

SPDR S&P Pharmaceuticals ETF

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Biotech Innovations Remain At Forefront

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those aged 65 years and older.

Moving Beyond COVID In Biopharma

Direxion Daily Semiconductor Bear 3x Shares

Direxion's weekly ETF fund flows could shed light on what traders are thinking. The top three point to interest in long-term bond prices, biotech strength, and semiconductor weakness.

These 3 Popular ETFs Are Geared Toward Tactical Plays

U.S. president Joe Biden's infrastructure plan is opening up ETF trading possibilities from multiple angles. One way is playing its healthcare component via funds like the Direxion Daily Healthcare Bull 3X ETF (CURE) and the Direxion Daily S&P Biotech Bull 3X ETF (LABU).

Biden's Infrastructure Can Put These 2 Leveraged Funds in Play

Direxion Daily Aerospace & Defense Bull 3X Shares

Direxion Daily Regional Banks Bull 3X Shares

Direxion Daily Real Estate Bull 3x Shares

Novavax

Direxion Daily Retail Bull 3X Shares

Direxion Daily Small Cap Bull 3x Shares

ProShares UltraPro Russell2000

Direxion Daily Consumer Discretionary Bull 3X Shares

The S&P 500, the Dow Jones, the Nasdaq Composite and the small-cap Russell 2000 were all on an uptrend last week.

6 Top Leveraged ETF Areas of Last Week

Direxion Daily Transportation Bull 3X Shares

Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X Shares

Direxion Daily Dow Jones Internet Bull 3X Shares

Investors flocked to leveraged ETFs to cash in on the opportunity offered by an improving economy and a rising stock market.

Leveraged ETFs In the Pink After 1 Year of Pandemic

6 Top Leveraged Areas of Last Week

United States Oil Fund LP

Solid corporate earnings and expectations of a fat stimulus by U.S. President Joe Biden's administration have renewed the appeal for the riskier assets last week.

6 Leveraged ETF Areas Up At Least 20% Last Week

AMC Entertainment

ProShares Ultra VIX Short-Term Futures ETF

The month of January was volatile for the global stock market.

5 Best-Performing Leveraged ETFs of January

The biotechnology industry isn't backing down, with ETFs like the Direxion Daily S&P Biotech Bull 3x Shares (LABU) gaining over 15% to start the new year. More strength could be ahead as the global economy continues to battle with the Covid-19 pandemic.

Up Over 100% in 2020 and 15% in 2021, ‘LABU' Isn't Holding Back

News for Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU)